Workflow
企业境外上市
icon
Search documents
芯海科技:拟筹划H股发行
Ge Long Hui· 2025-08-14 13:01
Core Viewpoint - The company, Chipsea Technologies (688595.SH), plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance its international strategy, competitiveness, and brand image while diversifying its financing channels [1] Group 1: International Strategy - The company aims to deepen its international strategic layout to improve overall competitiveness [1] - The issuance of H-shares is part of a broader effort to enhance the company's international brand image [1] Group 2: Regulatory Compliance - The company will comply with relevant laws and regulations, including the Company Law and Securities Law of the People's Republic of China, as well as the regulations for overseas issuance and listing [1] Group 3: Shareholder Consideration - The company will consider the interests of existing shareholders and the conditions of domestic and international capital markets when deciding the timing and window for the H-share issuance [1] - The issuance will be completed within 18 months following the approval of the shareholders' meeting [1]
万兴科技集团股份有限公司 关于筹划发行H股股票并在香港联合交易所有限公司 上市相关事项的提示性公告
Group 1 - The company plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance its global strategy and brand image [1][2] - The board of directors approved the proposal for the issuance and listing of H-shares during the fourth meeting of the fifth board on August 8, 2025 [1] - The issuance and listing are subject to approval from the shareholders' meeting and relevant regulatory bodies, including the China Securities Regulatory Commission and the Hong Kong Securities and Futures Commission [1][2] Group 2 - The company is actively discussing the details of the issuance and listing with relevant intermediaries, but specific details have not yet been finalized [2] - There is significant uncertainty regarding whether the issuance and listing will pass the necessary approvals and regulatory processes [2] - The company commits to timely information disclosure based on the progress of the issuance and listing [2]
可孚医疗: 关于筹划发行H股股票并在香港联合交易所有限公司上市的提示性公告
Zheng Quan Zhi Xing· 2025-08-08 16:23
Core Viewpoint - The company plans to issue H shares and apply for listing on the Hong Kong Stock Exchange to enhance its global strategy and brand recognition [1][2]. Group 1: Company Actions - The company convened its second board meeting and supervisory board meeting on August 7, 2025, where it approved the proposal for issuing H shares and listing on the Hong Kong Stock Exchange [1]. - The issuance aims to accelerate the company's global expansion and improve its overseas business capabilities [1]. Group 2: Regulatory Compliance - The issuance and listing are subject to approval from the company's shareholders and must comply with various legal requirements, including those from the China Securities Regulatory Commission and the Hong Kong Stock Exchange [2]. - The company is currently discussing the specifics of the issuance with relevant intermediaries, but details have not yet been finalized [2].
普源精电(688337.SH):筹划发行H股股票并在香港联交所上市相关事项
Ge Long Hui A P P· 2025-08-08 09:42
格隆汇8月8日丨普源精电(688337.SH)公布,为进一步提高公司综合竞争力,提升公司国际品牌形象, 同时更好地利用国际资本市场,多元化融资渠道,根据《中华人民共和国公司法》、《中华人民共和国 证券法》、《境内企业境外发行证券和上市管理试行办法》等相关法律、法规的规定,公司拟在境外发 行股份(H股)并在香港联合交易所有限公司(简称"香港联交所")主板上市。公司将充分考虑现有股 东的利益和境内外资本市场的情况,在股东大会决议有效期内(即自公司股东大会审议通过之日起24个 月或同意延长的其他期限)选择适当的时机和发行窗口完成本次发行H股并上市。 ...
华恒生物: 安徽华恒生物科技股份有限公司关于筹划公司在香港联合交易所有限公司上市的提示性公告
Zheng Quan Zhi Xing· 2025-07-30 16:24
证券代码:688639 证券简称:华恒生物 公告编号:2025-030 安徽华恒生物科技股份有限公司 关于筹划公司在香港联合交易所有限公司上市的 科创板股票上市规则》 《境内企业境外发行证券和上市管理试行办法》 《香港联合 交易所有限公司证券上市规则》等相关规定,待确定具体方案后,本次 H 股上市 工作尚需提交公司董事会和股东大会审议,并经中国证券监督管理委员会备案和 香港联交所等监管机构审核。 本次 H 股上市能否通过审议、备案和审核程序并最终实施具有较大不确定性。 公司将依据相关法律法规的规定,根据本次 H 股上市的后续进展情况及时履行信 息披露义务。本次 H 股上市尚存在较大不确定性,敬请广大投资者理性投资,注 意投资风险。 安徽华恒生物科技股份有限公司(以下简称"公司")为深入推进公司全球 化发展战略,提升品牌影响力与核心竞争力,巩固行业领先地位,充分借助国际 资本市场的资源与机制优势,优化资本结构,拓宽多元融资渠道,全面提升公司 治理水平和综合实力,正在筹划发行境外股份(H 股)并在香港联合交易所有限 公司(以下简称"香港联交所")上市事宜(以下简称"本次 H 股上市")。公司 正与相关中介机构就本 ...
滨化股份筹划赴港上市相关事项
Zhi Tong Cai Jing· 2025-07-29 08:37
滨化股份(601678)(601678.SH)公告,公司目前正在筹划境外发行股份(H股)并在中国香港联交所上市 事项。公司正在与相关中介机构就本次H股上市的具体推进工作进行商讨,相关细节尚未确定。 ...
滨化股份:筹划在香港联交所上市
news flash· 2025-07-29 08:06
Core Viewpoint - The company, Binhua Co., Ltd. (601678), is planning to issue H-shares and list on the Hong Kong Stock Exchange, which will not change the current controlling shareholder or actual controller situation [1] Group 1 - The H-share listing is subject to approval from the company's board and shareholders, as well as regulatory review by the China Securities Regulatory Commission and the Hong Kong Stock Exchange [1] - The company will fulfill its information disclosure obligations based on the progress of the H-share listing [1]
奥克斯香港上市获备案通知书,全球第五大空调提供商
Xin Lang Cai Jing· 2025-07-18 06:12
Group 1 - The new regulation effective from March 31, 2023, requires domestic companies to obtain a "filing notice" from the China Securities Regulatory Commission (CSRC) before listing in Hong Kong [1] - Aux Electric Co., Ltd. has received the filing notice for its overseas issuance and listing, allowing it to proceed with its plans [2][3] - The company plans to issue up to 517,500,000 ordinary shares for overseas listing on the Hong Kong Stock Exchange [3] Group 2 - Aux Electric has over 30 years of experience in the air conditioning industry, providing a range of products including household and central air conditioning systems [4] - The company operates in over 150 countries and regions, focusing on energy efficiency, comfort, health, and intelligence in its product offerings [4] - According to Frost & Sullivan, Aux Electric is the fifth largest air conditioning provider globally by sales volume, with a market share of 7.1% in 2024 [4] Group 3 - Aux Electric submitted its prospectus to the Hong Kong Stock Exchange on January 16, 2025, with China International Capital Corporation (CICC) as the sole sponsor [5]
警惕无形之“险”:无形资产实缴对上市企业的风险浅谈
Sou Hu Cai Jing· 2025-07-11 01:48
Group 1: Core Insights - The article highlights the risks and challenges associated with the contribution of intangible assets in the process of overseas listing for companies [2] - It emphasizes the need for companies to be aware of the potential legal and tax implications arising from the overvaluation of intangible assets [4][8] Group 2: Assessment Risks - There is a risk of inflated valuations of intangible assets, which can lead to legal liabilities for shareholders if the actual value is lower than the assessed value [5] - Assessment institutions may also face legal consequences if their evaluations are found to be inaccurate, as they are responsible for the accuracy of their reports [6] Group 3: Tax Risks - Personal income tax implications arise when shareholders contribute intangible assets, with a 20% tax on capital gains from the transfer of such assets [8] - Corporate income tax benefits can be affected by the overvaluation of intangible assets, leading to potential tax liabilities and penalties if discrepancies are identified by tax authorities [9] - Value-added tax (VAT) treatment varies based on the classification of intangible assets, with potential exemptions for technology-related assets if conditions are met [10] Group 4: Recommendations - Companies are advised to select reputable assessment institutions and establish internal review mechanisms to ensure fair valuations of intangible assets [12] - It is recommended to include liability clauses in contracts with assessment institutions to mitigate risks associated with inaccurate evaluations [12]
天赐材料拟赴港上市 业绩连降两年2021年定增募16.7亿
Zhong Guo Jing Ji Wang· 2025-07-08 03:24
Core Viewpoint - The company Tianqi Materials plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance its global strategy and competitiveness in the international market [1][2]. Group 1: H-Share Issuance - The company held board and supervisory meetings on July 4, 2025, to approve the proposal for issuing H-shares and listing on the Hong Kong Stock Exchange [1]. - The issuance aims to support the company's global strategy, meet the needs of overseas business development, and improve operational efficiency [1][2]. - The issuance requires approval from the shareholders' meeting and relevant regulatory bodies, including the China Securities Regulatory Commission and the Hong Kong Stock Exchange [2]. Group 2: Financial Performance - In 2024, the company reported a revenue of 12.52 billion yuan, a decrease of 18.74% compared to 2023 [3]. - The net profit attributable to shareholders was 483.93 million yuan, down 74.40% year-on-year [3]. - The net profit after deducting non-recurring gains and losses was 381.60 million yuan, reflecting a decline of 79.08% [3]. - The net cash flow from operating activities was 881.54 million yuan, a decrease of 61.24% compared to the previous year [3]. Group 3: Historical Financial Data - In 2023, the company achieved a revenue of 15.40 billion yuan, down 30.97% from 2022 [4]. - The net profit attributable to shareholders in 2023 was 1.89 billion yuan, a decline of 66.92% year-on-year [4]. - The net profit after deducting non-recurring gains and losses for 2023 was 1.82 billion yuan, down 67.08% compared to 2022 [4]. - The net cash flow from operating activities in 2023 was 2.27 billion yuan, a decrease of 45.38% from 2022 [4].